Skip to main content

Published locations for FDA approves acalabrutinib for CLL, SLL treatment

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA approves acalabrutinib for CLL, SLL treatment

User login

  • Reset your password
  • /content/fda-approves-acalabrutinib-cll-sll-treatment
  • /hematologynews/article/212865/cll/fda-approves-acalabrutinib-cll-sll-treatment
  • /oncologypractice/article/212865/cll/fda-approves-acalabrutinib-cll-sll-treatment
  • /hematology-oncology/article/212865/cll/fda-approves-acalabrutinib-cll-sll-treatment
  • /hematologytimes/article/212865/cll/fda-approves-acalabrutinib-cll-sll-treatment
  • /b-cell-lymphoma-icymi/article/212865/cll/fda-approves-acalabrutinib-cll-sll-treatment